Bristol-Myers Squibb (BMY)

$44.24 0.57 (1.29%)

14:15 EDT BMY Stock Quote Delayed 30 Minutes

Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields

By Alex Sirois, InvestorPlace Contributor May 6, 2024

Investing in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time.

Uncover the Potential: 3 Discounted Stocks Ready for a Comeback

BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024

Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts

Volume:

Previous Close -

Market Cap 98.30B

PE Ratio -14.27

EPS -3.1

Volume (Avg. Vol.) 4.53M

Day's Range $43.50 - $44.32

52-Week Range $43.33 - $69.10

Dividend & Yield $2.28 (5.15%)

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

From InvestorPlace
From the Web

5 Crash-Proof Stocks to Buy Immediately

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Apr 22, 2024

We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks.

3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500

By Bob Ciura, Sure Dividend Apr 17, 2024

If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.

3 Pharma Stocks That Are Money-Printing Machines in 2024

By Michael Que, InvestorPlace Contributor Apr 15, 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

Wall Street Favorites: 3 Warren Buffett Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor Apr 12, 2024

If you’re wondering where to invest in a stock picker's market, these three Warren Buffett stocks are a good place to start.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

By Muslim Farooque, InvestorPlace Contributor Apr 11, 2024

Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

By Joey Frenette, InvestorPlace Contributor Apr 5, 2024

The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

The Bargain Hunter’s Dream: 3 Underpriced Stocks Poised for Massive Gains

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 1, 2024

Three well-known companies stick out among the market's complexity as excellent chances for investors looking for significant gains.

The 3 Best Biotech Stocks to Buy in Q2 2024

By Chandler Capital, InvestorPlace Contributor Mar 29, 2024

Biotech can be a risky industry for investors, but we've done the legwork for you with these three biotech stocks for Q2.

The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio

By Josh Enomoto, InvestorPlace Contributor Mar 27, 2024

With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation…

Millionaire’s Blueprint: 7 Must-Have Stocks for Your Road to Wealthy Town

By Yiannis Zourmpanos, InvestorPlace Contributor Mar 6, 2024

Discover must-have stocks for wealth for every investor, from healthcare and communication giants to financial and industrial sectors.

Mental Health Mavericks: 3 Stocks Changing the Game

By Will Ashworth, InvestorPlace Contributor Feb 21, 2024

Except for the psychedelics movement, there seem to be very few mental health stocks to buy that are making money.

The 3 Best Stocks Beginning Investors Can Buy: February 2024

By Tezcan Gecgil, InvestorPlace Contributor Feb 21, 2024

Starting your investment journey? Navigate the market with confidence! Discover 3 stocks for beginning investors in this article.

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

7 Dividend Stocks to Buy at a 52-Week Low

By Chris Markoch, InvestorPlace Contributor Feb 12, 2024

Each of these dividend stocks has been down sharply in the last 12 months but has fundamental reasons that support a turnaround.

7 Biotech Stocks Fighting America’s Deadliest Diseases

By Josh Enomoto, InvestorPlace Contributor Feb 8, 2024

Unlike many other market segments, biotech stocks stand out for their direct relevance. For example, investors who typically wager on aerospace and defense plays usually…

3 Blue-Chip Stocks to Buy at a 52-Week Low in February

By Chris Markoch, InvestorPlace Contributor Feb 7, 2024

Higher-for-longer interest rates and undervalued metrics make it a good time to look for blue-chip stocks at a low price.

Undervalued Gems: 7 Stocks Set for a Major Rebound

By Thomas Niel, InvestorPlace Contributor Feb 5, 2024

Each of these seven undervalued stocks has fallen by 25% or more from its 52-week high, but may have a path back to prior prices.

3 Healthcare Stocks at 52-Week Lows: Buy or Bye?

By Alex Sirois, InvestorPlace Contributor Jan 26, 2024

Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.

7 Beaten-Down Value Stocks Poised for an Epic Turnaround

By Omor Ibne Ehsan Jan 23, 2024

Battered value stocks could be priced for an epic rebound in 2024 and beyond. These seven can quickly escape Wall Street's penalty box.

3 Dividend Stocks for Strong Returns in 2024 and Beyond

By Bob Ciura, Sure Dividend Jan 4, 2024

Investors should consider these three dividend stocks for 2024 and beyond, as they offer compelling yields and safety.

Bristol-Myers Squibb (BMY)

Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields

Uncover the Potential: 3 Discounted Stocks Ready for a Comeback

BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024

Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Bristol-Myers Squibb (BMY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

Subscriber Sign in